Eloxx Pharmaceuticals Inc <ELOX.O>: Guggenheim initiates coverage with buy rating; target price $43
ELOX•Related News
Icahn Enterprises to sell auto-service chain Pep Boys to Mavis for $700 million, WSJ reports
IEP•
Clover Health Chief Legal Officer Karen Soares disposes of 51,700 common shares for $233,167
CLOV•
Ridgetech director Kong Lingtao files initial beneficial ownership statement
RDGT•
Aktis Oncology director Ken Herrmann disposes of 3,065 common shares worth $77,279.54
AKTS•
SmartFinancial Q2 profit rises as loan growth lifts net interest income
SMBK•